Disease mongering
This page lists 62 references in the Main Healthy Skepticism Library relevant to disease mongering.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL11396
Olijhoek JK, van der Graaf Y, Haffner SM, Visseren FL; for the SMART Study Group.
Defining the metabolic syndrome: Resolving unresolved issues?
Eur J Intern Med 2007 Jul;18(4):309-13
http://linkinghub.elsevier.com/retrieve/pii/S0953-6205(07)00082-9
HSL6927
Cassels A.
Cholesterol TV ads clog reality
Common Ground Magazine 2006 Nov 1
HSL6141
Dobson R.
More evidence suggests that PSA testing leads to “overdiagnosis” of cancer
BMJ 2006 Jul 21;333(7560):166
http://bmj.bmjjournals.com/cgi/content/short/333/7560/166-a?etoc%3e
HSL6151
Rigby N.
Obesity association clarifies definitions of obesity and links with drug firms.
BMJ 2006 Jul 1;333(7557):44
http://bmj.bmjjournals.com/cgi/content/full/333/7557/44
HSL6553
Ghaemi SN.
The newest mania: seeing disease mongering everywhere.
PLoS Med 2006 Jul 01;3(7):e319
Link to source with long URL
HSL6554
Amaral OB.
Defining disease in the information age.
PLoS Med 2006 Jul 01;3(7):e317
Link to source with long URL
HSL6555
Gillman K.
Disease mongering: one of the hidden consequences.
PLoS Med 2006 Jul 01;3(7):e316
Link to source with long URL
HSL5807
Sutcliffe AG, Wong IC.
Rational prescribing for children.
BMJ 2006 Jun 24;332(7556):1464-5
http://bmj.bmjjournals.com/cgi/content/full/332/7556/1464
HSL5735
Ferner RE, McDowell SE.
How NICE may be outflanked.
BMJ 2006 May 27;332(7552):1268-71
http://bmj.bmjjournals.com/cgi/content/full/332/7552/1268
HSL5491
Wager E.
Making themselves sicke by phantsye
BMJ 2006 May 13;332(7550):1152
http://bmj.bmjjournals.com/cgi/content/short/332/7550/1152?etoc
HSL6655
Bundesministerium fur Gesundheit.
[Regulation for control of advertising cosmetic operations set into effect].
Kinderkrankenschwester 2006 May 01;25(5):211
HSL5498
Dyer O.
Disease awareness campaigns turn healthy people into patients.
BMJ 2006 Apr 15;332(7546):871
http://bmj.bmjjournals.com/cgi/content/full/332/7546/871
HSL5582
Moldrup C, Hansen RR.
Public acceptance of drug use for non-disease conditions.
Curr Med Res Opin 2006 Apr;22(4):775-80
Link to source with long URL
HSL8515
Mintzes B.
Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
PLoS Med 2006 Apr;3(4)
Link to source with long URL
HSL5740
Hammond I.
Selling sickness.
Can Assoc Radiol J 2006 Feb 01;57(1):11-2
HSL5737
Hall SS.
The short of it: more short children are being given growth hormone in the hope that an extra inch will protect their supposedly fragile psyches. But research suggests that their height is a problem less for them than for us.
N Y Times Mag 2005 Oct 16;:54-9
HSL2732
Sharfstein SS.
Big Pharma and American Psychiatry: The Good, the Bad, and the Ugly.
Psychiatric News 2005 Aug 19;40(16):3
http://pn.psychiatryonline.org/cgi/content/full/40/16/3
HSL2658
Smith DE, Wilson AJ, Henry DA.
Monitoring the quality of medical news reporting: early experience with media doctor.
Med J Aust 2005 Aug 15;183(4):190-3
http://www.mja.com.au/public/issues/183_04_150805/smi10755_fm.html
HSL6663
Mbongue TB, Sommet A, Pathak A, Montastruc JL.
'Medicamentation' of society, non-diseases and non-medications: a point of view from social pharmacology.
Eur J Clin Pharmacol 2005 Jun 01;61(4):309-13
http://www.springerlink.com/content/t212237555u30773/
HSL1880
Maher S.
Drug companies 'talk up' ailments
The Australian 2005 May 30
HSL1878
Pringle E.
TeenScreen: Who Pays for Treatment and Drugs?
Independent Media TV 2005 May 28
HSL1833
Pollack A.
Marketing a Disease, and Also a Drug to Treat It
The New York Times 2005 May 9
HSL1876
Pringle E.
Bush-Backed Drug Marketing Schemes
The Sierra Time 2005 Apr 26
HSL2235
Moynihan R.
The marketing of a disease: female sexual dysfunction.
BMJ 2005 Jan 22;330(7484):192-4
http://bmj.bmjjournals.com/cgi/content/full/330/7484/192
HSL1925
Waack KE, Ernst ME, Graber MA.
Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
Ann Pharmacother 2004 Dec;38(12):2029-34
http://www.theannals.com/cgi/content/full/38/12/2029
HSL5392
Caplan A, Elliott C.
Is it ethical to use enhancement technologies to make us better than well?
PLoS Med 2004 Dec;1(3):e52
Link to source with long URL
HSL2076
Centers for Disease Control and Prevention (CDC).
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
MMWR Morb Mortal Wkly Rep 2004 Jul 16;53(27):603-6
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5327a1.htm
HSL2820
Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG, Peterson JA.
Effects of information on college students' perceptions of antidepressant medication.
J Am Coll Health 2004 Jul-Aug;53(1):35-40
HSL2803
Lakoff , A.
The anxieties of globalization: antidepressant sales and economic crisis in Argentina
Soc Stud Sci 2004 Apr;34(2):247-69
HSL293
Moynihan R.
Controversial disease dropped from Prozac product information.
BMJ 2004 Feb 14;328(7436):365
http://bmj.bmjjournals.com/cgi/content/full/328/7436/365
HSL295
Metzl JM, Angel J.
Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness.
Soc Sci Med 2004 Feb;58(3):577-84
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-497YSNG-
HSL4139
Anonymous .
Merck & co invents new syndromedinformation deprivation.
Scrip. 2004;2983:5
HSL1409
Mechanic D.
Is the prevalence of mental disorders a good measure of the need for services?
Health Aff (Millwood) 2003 Sep-Oct;22(5):8-20
http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=14515877
HSL1462
Burgmer M, Driesch G, Heuft G.
[The "Sisi syndrome": a new form of depression?]
Nervenarzt 2003 May;74(5):440-4
HSL1227
Cohen P.
Visions and Revisions of Child-Raising Experts
The New York Times 2003 Apr 5
HSL2683
Cassels A.
Consumer drug advertising leads to MD backlash in Holland.
CMAJ 2002 Oct 1;167(7):793
http://www.cmaj.ca/cgi/content/full/167/7/793
HSL1662
Jureidini J.
Does the International Consensus Statement on ADHD leave room for healthy scepticism?
Eur Child Adolesc Psychiatry 2002 Oct;11(5):240
HSL2439
Sackett DL.
The arrogance of preventive medicine.
CMAJ 2002 Aug 20;167(4):363-4
http://www.cmaj.ca/cgi/content/full/167/4/363
HSL2452
Moynihan R, Heath I, Henry D.
Selling sickness: the pharmaceutical industry and disease mongering.
BMJ 2002 Apr 13;324(7342):886-91
http://bmj.bmjjournals.com/cgi/content/full/324/7342/886
HSL2310
Moynihan R.
Drug firms hype disease as sales ploy, industry chief claims.
BMJ 2002 Apr 13;324(7342):867
http://bmj.bmjjournals.com/cgi/content/full/324/7342/867
HSL2898
Bonaccorso S, Sturchio J.
Direct to consumer advertising is medicalising normal human experience: Against
BMJ 2002 Apr 13;324(7342):910-911
http://bmj.com/cgi/content/full/324/7342/910
HSL2755
Belkin , L .
Prime time pushers
2001 Mar:31-37
http://motherjones.com/magazine/MA01/drug.html
HSL2962
Meek C.
2001
www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL1659
Jureidini JN.
Epidemic of schizophrenia in children or inappropriate prescribing?
Med J Aust 2000 Nov 20;173(10):555-6
HSL690
Palmlund I.
The marketing of estrogens for menopausal and postmenopausal women.
J Psychosom Obstet Gynaecol 1997 Jun;18(2):158-64
Nil
HSL791
Gilbert D, Chetley A.
New trends in drug promotion
Consumer Policy Review 1996;63(5):162-167
HSL4813
Data JL, Barton KS.
Advertising baldly to the public
New England Journal of Medicine 1992;326:330-331
HSL4863
Montagne M.
The promotion of medications for personal and social problems
Journal of Drug Issues 1992;22:389-405
HSL4909
Sorofman B.
Drug promotion in self-care and self-medication
Journal of Drug Issues 1992;22:377-388
HSL4510
Berube B.
The subtle sell: an overview
Canadian Pharmaceutical Journal 1990;123:397-398
HSL4467
Prescriptions for profit
1989 Mar 28
HSL4130
Burton JL.
Baldness and minoxidil advertising
Lancet 1989;1:442-443
HSL4072
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988
HSL3679
Liebman M.
Prescription drug advertising to the general public.
Hosp Pract (Off Ed) 1984 May;19(5):13,
HSL3583
Gray R, Smith M.
Is criticism of tranquilizer advertising justified?
Medical Marketing & Media 1983;18(7):50, 52, 54-55, 58-59
HSL3547
Melville A, Johnson C.
Cured to death: the effects of prescription drugs
1982
HSL3514
Koumjian K.
The use of valium as a form of social control.
Soc Sci Med [E] 1981 Aug;15(3):245-9
HSL3235
Findings and conclusions of the NCCC [National Council of Churches of Christ] project on drug advertising
Journal of Drug Issues 1974;4:310-312
HSL3237
Cooperstock R.
Some factors involved in the increased prescribing of psychotropic drugs
Alcoholism and Drug Addiction Research Foundation of Ontario 1974
HSL3261
Johnson N.
Junkie television
Journal of Drug Issues 1974;4:227-231
HSL3188
Seidenberg R.
Advertising and abuse of drugs.
N Engl J Med 1971 Apr 8;284(14):789-90
HSL2935
Lennard HL, Epstein LJ, Bernstein A, Ransom DC.
Hazards implicit in prescribing psychoactive drugs.
Science 1970 Jul 31;169(944):438-41